Log in to save to my catalogue

Lipid Nanoparticle Systems for Enabling Gene Therapies

Lipid Nanoparticle Systems for Enabling Gene Therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5498813

Lipid Nanoparticle Systems for Enabling Gene Therapies

About this item

Full title

Lipid Nanoparticle Systems for Enabling Gene Therapies

Publisher

United States: Elsevier Inc

Journal title

Molecular therapy, 2017-07, Vol.25 (7), p.1467-1475

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Genetic drugs such as small interfering RNA (siRNA), mRNA, or plasmid DNA provide potential gene therapies to treat most diseases by silencing pathological genes, expressing therapeutic proteins, or through gene-editing applications. In order for genetic drugs to be used clinically, however, sophisticated delivery systems are required. Lipid nanopa...

Alternative Titles

Full title

Lipid Nanoparticle Systems for Enabling Gene Therapies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5498813

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5498813

Other Identifiers

ISSN

1525-0016

E-ISSN

1525-0024

DOI

10.1016/j.ymthe.2017.03.013

How to access this item